China Capital Management
VC Fund
Beijing, China
China Capital Management is a direct investment business institutions for securities companies.
- Total investments:
- 93
- Last investment:
- Lead investor:
- 38%
- Fund size:
- $148M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries China Capital Management invests in
Stages China Capital Management invests in
Countries China Capital Management invests in
Round sizes
Round size
- Series A
- $7.4M–$55M
- Series B
- $3M–$28M
- Series C
- $4.8M–$283M
Investment Focus
Industry
- Manufacturing 27 (29%)
- Aerospace 13 (14%)
- Semiconductor 12 (13%)
- Electronics 9 (10%)
- Medical 7 (8%)
Stage
- Series A 29 (31%)
- Series B 19 (20%)
- Series C 13 (14%)
- Seed 12 (13%)
- Venture - Series Unknown 8 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Pulang Innovation is a semiconductor quantum dot light-emitting material and equipment developer, focusing on the research and development, production and sales of semiconductor quantum dot light-emitting materials, new quantum dot displays and semiconductor thin film process equipment. The company has quantum dot material research and development,synthesis, and production capabilities. It has core technology. The unique quantum dot coating technology solves the key problem of insufficient stability of quantum dot materials. The quantum dot optical film products produced by the company are in thickness (ultra-thin), Stability, edge failure, color gamut and other key indicators are in a leading position in China. The innovation of the wave makes the application of quantum dot technology in portable display devices a possibility. | Series A / Oct 14, 2026 | ||
| Yisheng New Materials has developed a W-coating thickness management technology that creates a highly thermally conductive interface between diamond and the metal substrate while avoiding damaging interfacial interactions. | $14.9M / Series A / Oct 13, 2026 | ||
| Baiqu Bio is a high-tech enterprise specializing in the application, consulting and development of cutting-edge research technology in life sciences. It is also an early detection and analysis service organization for comprehensive solutions of metabolomics in China. The company's core team has extensive experience in the field of metabolomicsin scientific research services, health testing, and industrial testing. Baiqu Bio focuses on mass spectrometry and metabolic testing, and continues to develop and research on metabolomics product innovation and technology. At present, it has a number of metabolomics patents, masters the core technology in the field of metabolomics, and is proud of the domestic metabolomics detection and analysis field. Achievements. Since its inception, the company's performance has maintained a steady growth momentum for consecutive years and has achieved profitability for six consecutive years. | $14.9M / Series B / Oct 10, 2026 | ||
| Haoxinqing is an online medical service platform focusing on the fields of mental psychology and chronic disease management. | $44.7M / Series D / Sep 30, 2026 | ||
| Zhongke lon engages in the R&D and manufacturing of high-end medical devices such as proton therapy equipment. It is committed to providing full-cycle solutions for the construction and operation of proton therapy centers and creating nuclear technology applications and medical equipment. The company was established in 2016 and is headquartered in Hefei, Anhui, China. | $89.5M / Seed / Sep 29, 2026 | ||
| Junhe Atom is a company that focuses on Small modular nuclear reactors. | $14.9M / Angel / Sep 25, 2026 | ||
|
Baiyue Interlink
|
Baiyue Interlink is a commercial aerospace company capable of reusable Level 1 and Level 2 space transportation. | Angel / Sep 24, 2026 | |
|
Qingwei Aviation
|
Qingwei Aviation is a company primarily focused on developing high-safety-level fly-by-wire flight control computing platforms and intelligent cockpit display systems tailored for general aviation and low-altitude economic (advanced air traffic) flight vehicles. The company aims to create next-generation avionics products that align with marketdemands and collaborates with partners to build a civil aircraft avionics ecosystem. | $7.5M / Seed / Sep 22, 2026 | |
| MileBot Robotics is a robot start-up company in the field of medical and health. It focuses on the research and development of cutting-edge technologies and medical products. It builds an intelligent rehabilitation system through robots, the Internet of Things, big data, and artificial intelligence. Adhering to the concept of “Technology to HelpWalk”, we regard our rehabilitation medical cause as our own responsibility. Through exoskeleton robots, we can help the disabled and the elderly to carry out rehabilitation training, so that science and technology can help patients regain their dignity. | $14.9M / Series B / Aug 26, 2026 | ||
| BoPixel is a supplier of high-performance machine vision core components, stable, reliable and machine vision products for global customers. | Series C / Aug 06, 2026 | ||
| See all 93 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does China Capital Management invest in?
China Capital Management invests primarily in Manufacturing, Aerospace and Semiconductor startups, most often at Series A and Series B stage. Most of the 93 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does China Capital Management invest in?
China Capital Management typically joins rounds of $7.4M–$55M at Series A, $3M–$28M at Series B and $4.8M–$283M at Series C. These are whole funding-round sizes, not China Capital Management's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds China Capital Management took part in.
When did China Capital Management last invest?
The most recent investment recorded for China Capital Management closed in Oct 2026. Shizune tracks 93 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
